NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bacitracin | BACITRACIN | Water-Jel Technologies | 412928a1-3708-4fa8-99c5-aaa2b079cf6e | 2025-01-06 | Warnings | M004 1366116 89Y4M234ES |
| Neomycin and Polymyxin B Sulfates and Bacitracin Zinc | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND BACITRACIN ZINC | Bausch & Lomb Incorporated | f3231f1c-665e-4efa-baa1-83bf296b2f8f | 2025-01-02 | Warnings, Adverse reactions | 89Y4M234ES |
| Neomycin and Polymyxin B Sulfates, Bacitracin Zinc and Hydrocortisone | NEOMYCIN SULFATE AND POLYMYXIN B SULFATE, BACITRACIN ZINC AND HYDROCORTISONE | Bausch & Lomb Incorporated | 3b00eb5c-dd98-467e-a883-04c37a8ecc42 | 2025-01-02 | Warnings, Adverse reactions | 89Y4M234ES |
| AVON HeXashield Triple Antibiotic with Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HCL | Tai Guk Pharm. Co., Ltd. | 8e0cb861-d8aa-1f71-e053-2a95a90aaa88 | 2025-01-01 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Trifecta Pharmaceuticals USA LLC | 087694c2-4b1b-e293-e063-6294a90a961f | 2024-12-31 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE | TRIFECTA PHARMACEUTICALS USA LLC | 0c017b10-29b6-e30f-e063-6294a90a8a3c | 2024-12-31 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic and Pain Relief | BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINE | Trifecta Pharmaceutical USA LLC | 0bf08cf6-be3f-f9aa-e063-6294a90a4393 | 2024-12-31 | Warnings | M004 89Y4M234ES |
| Vitamin A and D | PETROLATUM | Trifecta Pharmaceuticals USA LLC | f1ea9640-4a6d-1c76-e053-2a95a90ad3b1 | 2024-12-31 | Warnings | 4T6H12BN9U |
| Lubricant Eye PM | MINERAL OIL, WHITE PETROLATUM | Reliable 1 Laboratories LLC | baec8045-97fe-6f60-e053-2a95a90a050e | 2024-12-31 | Warnings | T5L8T28FGP |
| A and D Diaper Rash and Skin Protectant | LANOLIN AND PETROLATUM | Natureplex LLC | fcaf27c9-3634-4fb7-a311-2e093f055278 | 2024-12-31 | Warnings | 4T6H12BN9U |
| Single Antibiotic with Bacitracin | BACITRACIN ZINC | Randob Labs Ltd. | 2a807f1b-986f-a9ea-e063-6394a90aed25 | 2024-12-30 | Warnings | M004 89Y4M234ES |
| Bacitracin Zinc and Polymyxin B Sulfate | BACITRACIN ZINC AND POLYMYXIN B SULFATE | NuCare Pharmaceuticals,Inc. | a73654f4-949d-3da4-e053-2995a90a1fc3 | 2024-12-30 | Warnings, Adverse reactions | 89Y4M234ES |
| ELIZABETH ARDEN EIGHT HR PROTECTANT CLEAR | LIP PROTECTANT | REVLON CONSUMER PRODUCTS CORP | f3a6fe29-7af7-bfb1-e053-2a95a90a0101 | 2024-12-30 | Warnings | 4T6H12BN9U |
| AD Medicated Rash | AD MEDICATED RASH | WellSpring Pharmaceutical Corporation | aac345bf-ea66-4f5b-a497-c24ea72f93ea | 2024-12-27 | Warnings | T5L8T28FGP |
| EIGHT HOUR LIP PROTECTANT SPF 15 | PETROLATUM, OXYBENZONE, OCTINOXATE, AVOBENZONE | REVLON | 2a0ac6aa-0315-d79e-e063-6294a90a9c53 | 2024-12-24 | Warnings | 4T6H12BN9U |
| CUREFINI | PETROLATUM, COD LIVER OIL | Miramar Cosmetics, Inc DBA Miramar Lab | fc9211db-71aa-44d8-a00b-65f1482d3981 | 2024-12-23 | Warnings | 4T6H12BN9U |
| CUREFINI | PETROLATUM | Miramar Cosmetics, Inc DBA Miramar Lab | 6a2610ca-ca80-451f-8fed-b982443a10b9 | 2024-12-23 | Warnings | 4T6H12BN9U |
| Tripleantibioticapainscaritch | FAMILY WELLNESS BACITRACIN,NEOMYCIN,POLYMYXINB,PRAMOXINEHCL | Trifecta Pharmaceutical USA LLC | 935106c6-8a9e-07fa-e053-2a95a90a2484 | 2024-12-20 | Warnings | M004 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | TRIFECTA PHARMACEUTICALS USA LLC | 00c52a31-9bfa-a8bf-e063-6294a90ac4d7 | 2024-12-20 | Warnings | M004 89Y4M234ES |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE | Trifecta Pharmaceuticals Usa Llc | d04b397c-1608-4fd9-be28-ef7285d6a996 | 2024-12-20 | Warnings | M004 89Y4M234ES |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.